• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科癌症家庭心理社会风险筛查:心理社会评估工具(PAT)第 3 版的验证。

Screening for Family Psychosocial Risk in Pediatric Cancer: Validation of the Psychosocial Assessment Tool (PAT) Version 3.

机构信息

Nemours Children's Health System.

Sidney Kimmel Medical School, Thomas Jefferson University.

出版信息

J Pediatr Psychol. 2018 Aug 1;43(7):737-748. doi: 10.1093/jpepsy/jsy012.

DOI:10.1093/jpepsy/jsy012
PMID:29509908
Abstract

OBJECTIVE

Family psychosocial risk screening is an important initial step in delivering evidence-based care. The Psychosocial Assessment Tool (PAT) is a brief parent report screener based on the trilevel Pediatric Psychosocial Preventative Health Model (PPPHM; Universal, Targeted, Clinical). The current article validates a revised PAT (version 3.0) in pediatric oncology that includes new items (for families of younger patients; clinically relevant risk items) and applicable to broad health literacy levels (a 4th grade reading level).

METHODS

Primary caregivers of 394 children newly diagnosed with cancer participated in this multisite investigation, completing the PAT and validation measures using REDCap.

RESULTS

The original structure of the PAT, with seven subscales (Family Structure, Social Support, Child Problems, Sibling Problems, Family Problems, Stress Reactions, and Family Beliefs) was supported using a confirmatory factor analysis. Internal consistency for the total score (Kuder-Richardson 20 coefficient [KR20] = 0.81) and the subscales (KR20 = 0.59-0.85) was moderate to strong. Moderate to strong correlations with the criteria measures provided validation for the total and subscale scores. The validation measures varied significantly, as expected, across the three levels of the PPPHM. Receiver operating characteristic (ROC) analyses showed that the PAT total and subscale scores can discriminate families above and below clinical thresholds.

CONCLUSIONS

Results reinforce the psychometric properties of this approach for screening of family psychosocial risk. The PAT provides an evidence-based screener that identifies families at three levels of risk and can provide the basis for further evaluation and treatment of children with cancer and their families.

摘要

目的

家庭心理社会风险筛查是提供循证护理的重要初始步骤。心理社会评估工具(PAT)是一种基于三层次儿科心理社会预防保健模型(PPPHM;普遍、靶向、临床)的简短家长报告筛查工具。本文验证了一种新的儿科肿瘤学修订版 PAT(第 3.0 版),其中包括新的项目(适用于年龄较小的患者的家庭;临床相关风险项目)和适用于广泛健康素养水平的项目(四年级阅读水平)。

方法

394 名新诊断为癌症的儿童的主要照顾者参与了这项多地点研究,他们使用 REDCap 完成了 PAT 和验证措施。

结果

使用验证性因子分析支持 PAT 的原始结构,该结构有七个分量表(家庭结构、社会支持、儿童问题、兄弟姐妹问题、家庭问题、应激反应和家庭信念)。总分(Kuder-Richardson 20 系数[KR20] = 0.81)和分量表(KR20 = 0.59-0.85)的内部一致性为中等至较强。与标准测量的中度至强相关性为总分和分量表得分提供了验证。验证措施在 PPPHM 的三个层次上有显著差异。接收者操作特征(ROC)分析表明,PAT 总分和分量表得分可区分高于和低于临床阈值的家庭。

结论

结果加强了这种方法用于筛查家庭心理社会风险的心理测量特性。PAT 提供了一种基于证据的筛查工具,可识别处于三个风险水平的家庭,并可为进一步评估和治疗癌症儿童及其家庭提供基础。

相似文献

1
Screening for Family Psychosocial Risk in Pediatric Cancer: Validation of the Psychosocial Assessment Tool (PAT) Version 3.儿科癌症家庭心理社会风险筛查:心理社会评估工具(PAT)第 3 版的验证。
J Pediatr Psychol. 2018 Aug 1;43(7):737-748. doi: 10.1093/jpepsy/jsy012.
2
Validation of the Spanish Version of the Psychosocial Assessment Tool (PAT) in Pediatric Cancer.《心理社会评估工具(PAT)西班牙语版在儿科癌症中的验证》。
J Pediatr Psychol. 2018 Nov 1;43(10):1104-1113. doi: 10.1093/jpepsy/jsy046.
3
Screening for Family Psychosocial Risk in Pediatric Hematopoietic Stem Cell Transplantation with the Psychosocial Assessment Tool.使用心理社会评估工具对儿科造血干细胞移植中的家庭心理社会风险进行筛查。
Biol Blood Marrow Transplant. 2019 Jul;25(7):1374-1381. doi: 10.1016/j.bbmt.2019.03.012. Epub 2019 Mar 14.
4
Validating the Factor Structure of the Psychosocial Assessment Tool Using Internet-Based Data.使用基于互联网的数据验证心理社会评估工具的因子结构。
J Pediatr Psychol. 2022 Feb 14;47(2):215-224. doi: 10.1093/jpepsy/jsab116.
5
Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool.镰状细胞病的心理社会筛查:心理社会评估工具的验证。
J Pediatr Psychol. 2020 May 1;45(4):423-433. doi: 10.1093/jpepsy/jsaa002.
6
Stability and change in family psychosocial risk over 6 months in pediatric cancer and its association with medical and psychosocial healthcare utilization.6 个月内儿科癌症家庭心理社会风险的稳定性和变化及其与医疗和心理社会保健利用的关系。
Pediatr Blood Cancer. 2020 Feb;67(2):e28051. doi: 10.1002/pbc.28051. Epub 2019 Nov 14.
7
Family Psychosocial Risk Screening in Infants and Older Children in the Acute Pediatric Hospital Setting Using the Psychosocial Assessment Tool.在急性儿科医院环境中使用心理社会评估工具对婴幼儿和大龄儿童进行家庭心理社会风险筛查。
J Pediatr Psychol. 2016 Aug;41(7):820-9. doi: 10.1093/jpepsy/jsw055. Epub 2016 Jun 24.
8
Family psychosocial risk screening guided by the Pediatric Psychosocial Preventative Health Model (PPPHM) using the Psychosocial Assessment Tool (PAT).采用心理社会评估工具(PAT),以儿童心理社会预防性健康模型(PPPHM)为指导进行家庭心理社会风险筛查。
Acta Oncol. 2015 May;54(5):574-80. doi: 10.3109/0284186X.2014.995774. Epub 2015 Mar 9.
9
Identifying Psychosocial Risk Factors Among Families of Children With Craniofacial Conditions: Validation of the Psychosocial Assessment Tool-Craniofacial Version.识别颅面疾病患儿家庭中的心理社会风险因素:心理社会评估工具-颅面版的验证
Cleft Palate Craniofac J. 2018 Apr;55(4):536-545. doi: 10.1177/1055665617748010. Epub 2018 Jan 9.
10
Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool.儿科癌症中的家庭心理社会风险、困扰及服务利用情况:心理社会评估工具的预测效度
Cancer. 2009 Sep 15;115(18 Suppl):4339-49. doi: 10.1002/cncr.24587.

引用本文的文献

1
Supervised machine learning applied in nursing notes for identifying the need of childhood cancer patients for psychosocial support.监督式机器学习应用于护理记录,以识别儿童癌症患者对心理社会支持的需求。
Front Digit Health. 2025 Aug 7;7:1585309. doi: 10.3389/fdgth.2025.1585309. eCollection 2025.
2
"We are here too": Experiences and perceived support needs of adolescent siblings of Paediatric oncology inpatients.“我们也在这里”:儿科肿瘤住院患者青少年兄弟姐妹的经历及感知到的支持需求
Br J Health Psychol. 2025 Feb;30(1):e12785. doi: 10.1111/bjhp.12785.
3
Assessing psychosocial risk factors in children with Sickle Cell Disease.
评估镰状细胞病患儿的心理社会风险因素。
BMC Health Serv Res. 2025 Jan 18;25(1):99. doi: 10.1186/s12913-025-12266-y.
4
Call to Action: Screening and Addressing Caregiver Mental Health Needs within all Pediatric Medical Subspecialty Settings as Standard of Care.行动呼吁:在所有儿科医学亚专业环境中筛查并满足照顾者的心理健康需求,将其作为护理标准。
Clin Pract Pediatr Psychol. 2024 Sep;12(3):328-338. doi: 10.1037/cpp0000514. Epub 2024 Mar 7.
5
Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease. Neighborhood 劣势对镰状细胞病预防和急性护理利用的影响。
Pediatr Blood Cancer. 2025 Jan;72(1):e31422. doi: 10.1002/pbc.31422. Epub 2024 Nov 6.
6
The Effects of Having a Child with Cancer on Parental Psychology: A Cross-Sectional Study.孩子患癌症对父母心理的影响:一项横断面研究。
J Clin Med. 2024 Oct 9;13(19):6015. doi: 10.3390/jcm13196015.
7
Illness cognitions and parental stress symptoms following a child's cancer diagnosis.儿童癌症诊断后的疾病认知与父母压力症状
Front Psychol. 2024 Sep 24;15:1436231. doi: 10.3389/fpsyg.2024.1436231. eCollection 2024.
8
Tailored approach to participant recruitment and retention to maximize health equity in pediatric cancer research.针对参与者招募和保留的定制方法,以最大限度地提高儿科癌症研究中的健康公平性。
BMC Med Res Methodol. 2024 Jul 24;24(1):161. doi: 10.1186/s12874-024-02287-2.
9
Perceived social support and characteristics of social networks of families with children with special healthcare needs following the COVID-19 pandemic.新冠疫情后,有特殊医疗需求儿童的家庭的感知社会支持和社交网络特征。
Front Public Health. 2024 Feb 29;12:1322185. doi: 10.3389/fpubh.2024.1322185. eCollection 2024.
10
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.儿童、青少年和青年低级别脑胶质瘤患者进行 I/II 期临床试验的共识框架:国际儿科低级别脑胶质瘤联盟临床试验工作组制定的指南。
Neuro Oncol. 2024 Mar 4;26(3):407-416. doi: 10.1093/neuonc/noad227.